李小锦, 黄莹莹, 杨珍, 武欣, 庄朋伟, 张艳军. 基于效应基准的中药质量生物标志物研究策略J. 药学学报, 2019,54(2): 204-210. doi: 10.16438/j.0513-4870.2018-0943
引用本文: 李小锦, 黄莹莹, 杨珍, 武欣, 庄朋伟, 张艳军. 基于效应基准的中药质量生物标志物研究策略J. 药学学报, 2019,54(2): 204-210. doi: 10.16438/j.0513-4870.2018-0943
LI Xiao-jin, HUANG Ying-ying, YANG Zhen, WU Xin, ZHUANG Peng-wei, ZHANG Yan-jun. Research strategy for quality-biomarkers of traditional Chinese medicine based on effect benchmarksJ. Acta Pharmaceutica Sinica, 2019,54(2): 204-210. doi: 10.16438/j.0513-4870.2018-0943
Citation: LI Xiao-jin, HUANG Ying-ying, YANG Zhen, WU Xin, ZHUANG Peng-wei, ZHANG Yan-jun. Research strategy for quality-biomarkers of traditional Chinese medicine based on effect benchmarksJ. Acta Pharmaceutica Sinica, 2019,54(2): 204-210. doi: 10.16438/j.0513-4870.2018-0943

基于效应基准的中药质量生物标志物研究策略

Research strategy for quality-biomarkers of traditional Chinese medicine based on effect benchmarks

  • 摘要: 中药质量控制是其现代化和全球化发展的前提,目前基于化学基准和效应基准的双重质量控制已经得到了国内外学者的共识。人们通过大量的研究已经从药材基源、药材性状及显微特征、物质基础以及药效作用等方面入手,建立了一系列行之有效的质量控制方法。并且在基于化学基准的质量控制研究方面,已经在指纹图谱、DNA条形码、等效成分群、质量标志物等研究方面取得了丰硕的成果。然而由于中药在生长年限、产地、生长环境以及制剂工艺等各种影响因素的差异,导致基于化学基准的中药质量控制仍难以全面反映中药质量。目前仍存在单纯基于化学基准的中药质量标准如何准确体现中药质量的争议,如中药质量标准中所选择的指标性成分难以全面反映中药或其复方中全部成分,并且指标成分与中药效应(有效性和安全性)的关联性尚不明确。鉴于机体多信号通路级联反应及串扰所形成的复杂信号网络,以及中药多成分多靶点的协同调控作用,可能存在不同成分调控同一信号或网络的现象和在一定范围内某些化学成分量的变化并不足以引起相关信号网络效应变化的情况。因此,基于效应基准的中药质量控制可能成为中药质量标准的有益补充,本文提出了基于效应基准的中药质量生物标志物(Q-biomarker)研究策略,以期为中药质量控制研究提供一定方法学参考。

     

    Abstract: The quality control of traditional Chinese medicine provides the premise of its modernization and globalization. Currently, the dual quality control based on chemical benchmark and effect benchmark has been recognized domestically and internationally. Research efforts have lead to establishment of a series of effective quality control methods based on chemical components, medicinal properties, microscopic characteristics, material constituents and pharmacodynamic targets. In the study of quality control based on chemical benchmarks, fruitful results on fingerprints, DNA barcodes, and quality markers have been achieved. However, due to a variety of factors, such as growth period, origin, growth environment and preparation process of traditional Chinese medicine, the quality control of traditional Chinese medicine based on chemical benchmarks remains difficult to fully reflect the quality of traditional Chinese medicine. At present, there is still a dispute on how to accurately reflect the quality of traditional Chinese medicines based on chemical benchmarks. For example, the index components selected in the Chinese medicine quality standards are difficult to totally reflect all the components of Chinese medicine, and the relevance between the index components versus therapeutic effect is not yet clear. In view of the complex signal network by cascade reaction and crosstalk of multi-signaling pathways within an organism, and the coordinated regulation of multi-components and multi-targets of traditional Chinese medicine, there may be different components regulating the same signal network or situations where the amount of certain chemical components within a range is not sufficient to cause a change in the signal network. Therefore, the quality control of traditional Chinese medicine based on the effect benchmark may be a useful supplement to the quality standard of traditional Chinese medicine. This paper proposes a Q-biomarker research strategy based on the effect benchmark in order to provide a methodological reference for the quality control research of traditional Chinese medicine.

     

/

返回文章
返回